Previous 10 | Next 10 |
Fourth quarter revenue of $131.8 million Fourth quarter GAAP earnings per diluted share of $0.10 Fourth quarter non-GAAP earnings per diluted share of $0.46 Provides annual revenue and earnings guidance for 2020 PLEASANTON, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Natus Med...
The following slide deck was published by Natus Medical Incorporated in conjunction with this Read more ...
PLEASANTON, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for...
PLEASANTON, Calif., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders fo...
PLEASANTON, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for ...
The Board of Directors of Natus Medical (NASDAQ: NTUS ) has authorized the repurchase of up to $50M of the Company's common stock through December 12, 2021. More news on: Natus Medical Incorporated, Healthcare stocks news, Stocks on the move, Read more ...
PLEASANTON, Calif., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for...
Natus Medical Incorporated (NTUS) Q3 2019 Earnings Conference Call October 24, 2019, 16:30 PM ET Company Participants Jonathan Kennedy - President and CEO Drew Davies - EVP and CFO Conference Call Participants Jayson Bedford - Raymond James Brian Weinstein - William Blair ...
Image source: The Motley Fool. Natus Medical (NASDAQ: NTUS) Q3 2019 Earnings Call Oct 24, 2019 , 4:30 p.m. ET Operator Continue reading
Natus Medical (NASDAQ: NTUS ): Q3 Non-GAAP EPS of $0.36 misses by $0.02 ; GAAP EPS of $0.25 misses by $0.04 . More news on: Natus Medical Incorporated, Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Natus Medical Incorporated Company Name:
NTUS Stock Symbol:
NYSE Market:
Natus Medical Incorporated Website:
SAN MATEO, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Jonathan Kennedy to the role of Chief Financial Officer....
Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600 Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600 PR Newswire NEW YORK , July 21, 2022 /PRNewswire/ -- Novanta Inc....
MIDDLETON, Wis., July 21, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight se...